- Is Bright Side Navigating the Pathways of Cancer a tax-exempt 501(c)(3)?
- Yes. Bright Side Navigating the Pathways of Cancer is recognised by the IRS as a 501(c)(3) organisation (EIN 26-1574057). The IRS recognised Bright Side Navigating the Pathways of Cancer as tax-exempt in May 2008.
- What is Bright Side Navigating the Pathways of Cancer's EIN?
- Bright Side Navigating the Pathways of Cancer's Employer Identification Number (EIN) is 26-1574057. The EIN was assigned by the IRS in May 2008. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Bright Side Navigating the Pathways of Cancer do?
- Empower and support individuals impacted by cancer
- Where is Bright Side Navigating the Pathways of Cancer located?
- Bright Side Navigating the Pathways of Cancer is located at 2612 Cheverny DR, Mckinney, TX, 75070.
- When was Bright Side Navigating the Pathways of Cancer founded or recognised by the IRS?
- Bright Side Navigating the Pathways of Cancer was recognised by the IRS as a tax-exempt organisation in May 2008. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Bright Side Navigating the Pathways of Cancer's annual revenue?
- Bright Side Navigating the Pathways of Cancer reports $17K in latest available revenue per IRS records. Full Form 990 figures are available on the financials tab.
- Has Bright Side Navigating the Pathways of Cancer been auto-revoked by the IRS?
- No. Bright Side Navigating the Pathways of Cancer (EIN 26-1574057) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Bright Side Navigating the Pathways of Cancer listed in IRS Publication 78?
- Yes. Bright Side Navigating the Pathways of Cancer is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.
